Evolution and Transmission of Influenza Virus in Natural Human Infection
流感病毒在人类自然感染中的进化和传播
基本信息
- 批准号:10656435
- 负责人:
- 金额:$ 72.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-02 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAnimal ModelAntibodiesAntibody titer measurementCharacteristicsClinical DataCommunicable DiseasesCommunitiesCommunity-Acquired InfectionsDataDevelopmentEnrollmentEpidemiologyEvolutionFoundationsGenetic VariationGoalsHazard ModelsHemagglutininHouseholdHumanImmuneImmunityImmunization ProgramsIndividualInfectionInfluenzaIntegration Host FactorsJournalsKnowledgeMeasuresModelingMolecularMorbidity - disease rateMutationNational Institute of Allergy and Infectious DiseaseNatural SelectionsNeuraminidasePersonsPlayPopulationPredispositionProcessProductivityPropertyProteinsPublic HealthPublishingResearchResolutionSamplingSingle Nucleotide PolymorphismStrategic PlanningSwabTechnologyVaccinationVaccinesVariantViralViral HemagglutininsViral Load resultVirusWorkchronic infectioncohortcommunity settingcross reactivityepidemiologic dataflu transmissiongenetic varianthazardimmunological statusindexinginfluenza epidemicinfluenza virus straininfluenza virus vaccineinfluenzavirusinnovationmathematical modelmortalitynext generation sequencingnovelpressurerare variantseasonal influenzatooltransmission processuniversal influenza vaccineuniversal vaccinevaccine effectivenessvaccine efficacyvaccine-induced antibodiesviral transmissionwhole genome
项目摘要
Seasonal influenza epidemics result in significant morbidity and mortality, and vaccine effectiveness is
disappointingly low. The rapid evolution of influenza viruses is a major barrier to effective vaccines, as new
strains with different antigenic properties are continuously generated within a remarkably large population of
infected hosts. This problem was highlighted in the recent NIAID strategic plan for influenza and in PA-18-859,
which highlight key knowledge gaps with respect to influenza virus evolution in individuals and its transmission
between them. The long-term goal of this research is to elucidate the evolutionary and epidemiological dynamics
of influenza viruses in naturally infected human hosts. The objectives of this project are to use state-of-the-art
molecular approaches to define the host-level evolution of influenza and to identify correlates of infectivity and
transmission. This project will combine intensive sampling of viruses, matched sera, and clinical data from
naturally infected individuals and their contacts, which will allow for robust analyses of influenza evolution,
transmission, and spread. The feasibility of this approach is supported by published preliminary data, which show
that (i) serial sampling can be used to characterize the evolutionary dynamics of influenza viruses within naturally
infected people; (ii) next generation sequencing (NGS) can be used to identify transmission pairs and to estimate
the number of unique viral variants transmitted between individuals; (iii) temporal data on viral load and within-
host genetic diversity can inform mathematical models of transmission. Detailed analyses of influenza evolution
and transmission will be accomplished in three aims. (Aim 1) Identify the emergent antigenic variants that are
positively selected with hosts. NGS of serially sampled within-host viral populations will be used to identify
hemagglutinin and neuraminidase variants under positive selection within hosts and their relationship to host
immune status. The impact of these mutations on viral antigenicity will be evaluated using sera from enrolled
individuals. (Aim 2) Define the transmission bottleneck and the genetic variants that are transmitted. NGS of
serial samples from index cases and household contacts will be used to define household transmission chains,
the size of the transmission bottleneck, and which within host variants are transmitted. (Aim 3) Identify viral and
host factors associated with host susceptibility, infectivity, and transmission. A strain-specific household
transmission model, integrating molecular and epidemiologic data, will be used to estimate hazards of infection
from the community and each infected household contact. This work is innovative, because it leverages the
expertise of an existing productive team to combine state-of-the-art technologies for viral sequencing and
sophisticated modeling approaches to study influenza virus evolution and transmission in natural infection. The
proposed research is significant, because it will define the evolutionary dynamics of influenza viruses at the level
of individual hosts in a community setting.
季节性流感流行导致显著的发病率和死亡率,疫苗的有效性受到影响。
令人沮丧的低。流感病毒的快速进化是有效疫苗的主要障碍,
具有不同抗原特性的菌株在相当大的群体中连续产生,
感染的宿主最近NIAID的流感战略计划和PA-18-859强调了这一问题,
其中强调了有关流感病毒在个体中演变及其传播的关键知识差距
他们之间这项研究的长期目标是阐明进化和流行病学动态
流感病毒在自然感染的人类宿主中的作用。该项目的目标是使用最先进的
分子方法来定义流感的宿主水平演变,并确定传染性的相关性,
传输该项目将联合收割机结合病毒、匹配血清和临床数据的密集采样,
自然感染的个体及其接触者,这将允许对流感演变进行强有力的分析,
传播和扩散。这种方法的可行性得到了已公布的初步数据的支持,这些数据表明,
(i)连续采样可用于表征自然界中流感病毒的进化动力学,
感染者;(ii)下一代测序(NGS)可用于识别传播对并估计
个体之间传播的独特病毒变体的数量;(iii)关于病毒载量的时间数据,以及-
宿主遗传多样性可以为传播的数学模型提供信息。流感演变的详细分析
并且传输将在三个目标中完成。(Aim 1)识别出现的抗原变体,
积极选择与主机。将使用连续采样的宿主内病毒群体的NGS来鉴定
正选择作用下的血凝素和神经氨酸酶变异体及其与宿主的关系
免疫状态这些突变对病毒抗原性的影响将使用入组受试者的血清进行评价。
个体(Aim 2)定义传播瓶颈和被传播的遗传变异。NGS
将使用索引病例和家庭接触者的系列样本来确定家庭传播链,
传输瓶颈的大小,以及在主机变量中传输哪些变量。(Aim 3)识别病毒和
与宿主易感性、传染性和传播相关的宿主因素。一个特定的家庭
一个整合了分子学和流行病学数据的传播模型将被用来估计感染的危害
从社区和每个受感染的家庭接触。这项工作是创新的,因为它利用了
现有生产团队的专业知识,将最先进的病毒测序技术与联合收割机结合起来,
先进的建模方法,研究流感病毒的进化和自然感染的传播。的
拟议中的研究是重要的,因为它将定义流感病毒的进化动力学水平,
of individual个人hosts主机in a community社区setting设置.
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A rapid and flexible microneutralization assay for serological assessment of influenza viruses.
- DOI:10.1111/irv.13141
- 发表时间:2023
- 期刊:
- 影响因子:4.4
- 作者:Rumfelt, Kalee E. E.;Fitzsimmons, William J. J.;Truscon, Rachel;Monto, Arnold S. S.;Martin, Emily T. T.;Lauring, Adam S. S.
- 通讯作者:Lauring, Adam S. S.
Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants.
快速传播和严格的瓶颈限制了高传播性 SARS-CoV-2 变种的进化。
- DOI:10.1101/2022.10.12.511991
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Bendall,EmilyE;Callear,Amy;Getz,Amy;Goforth,Kendra;Edwards,Drew;Monto,ArnoldS;Martin,EmilyT;Lauring,AdamS
- 通讯作者:Lauring,AdamS
SARS-CoV-2 Genomic Diversity in Households Highlights the Challenges of Sequence-Based Transmission Inference.
- DOI:10.1128/msphere.00400-22
- 发表时间:2022-12-21
- 期刊:
- 影响因子:4.8
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Lauring其他文献
Adam Lauring的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Lauring', 18)}}的其他基金
Functional and genetic constraints on influenza virus replication and fidelity
流感病毒复制和保真度的功能和遗传限制
- 批准号:
10647866 - 财政年份:2022
- 资助金额:
$ 72.7万 - 项目类别:
Evolution and Transmission of Influenza Virus in Natural Human Infection
流感病毒在人类自然感染中的进化和传播
- 批准号:
10208680 - 财政年份:2020
- 资助金额:
$ 72.7万 - 项目类别:
Evolution and Transmission of Influenza Virus in Natural Human Infection
流感病毒在人类自然感染中的进化和传播
- 批准号:
10450656 - 财政年份:2020
- 资助金额:
$ 72.7万 - 项目类别:
Fidelity, robustness, and diversity in RNA virus evolution and pathogenesis
RNA 病毒进化和发病机制的保真度、稳健性和多样性
- 批准号:
9203613 - 财政年份:2016
- 资助金额:
$ 72.7万 - 项目类别:
Population Dynamics an Evolutionary Capacity of Viral Quasispecies
种群动态和病毒准种的进化能力
- 批准号:
8505754 - 财政年份:2009
- 资助金额:
$ 72.7万 - 项目类别:
Population Dynamics an Evolutionary Capacity of Viral Quasispecies
种群动态和病毒准种的进化能力
- 批准号:
8223315 - 财政年份:2009
- 资助金额:
$ 72.7万 - 项目类别:
Population Dynamics an Evolutionary Capacity of Viral Quasispecies
种群动态和病毒准种的进化能力
- 批准号:
8020917 - 财政年份:2009
- 资助金额:
$ 72.7万 - 项目类别:
Population Dynamics an Evolutionary Capacity of Viral Quasispecies
种群动态和病毒准种的进化能力
- 批准号:
7771747 - 财政年份:2009
- 资助金额:
$ 72.7万 - 项目类别:
Population Dynamics an Evolutionary Capacity of Viral Quasispecies
种群动态和病毒准种的进化能力
- 批准号:
7638771 - 财政年份:2009
- 资助金额:
$ 72.7万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2018
- 资助金额:
$ 72.7万 - 项目类别:
Postdoctoral Fellowships
The Structural and Metabolic Changes Associated with Ependymal Layer Disruption in the Age Continuum of Hydrocephalus - A Human and Animal Model Study
脑积水年龄连续体中与室管膜层破坏相关的结构和代谢变化 - 人类和动物模型研究
- 批准号:
376678 - 财政年份:2017
- 资助金额:
$ 72.7万 - 项目类别:
Studentship Programs
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2017
- 资助金额:
$ 72.7万 - 项目类别:
Postdoctoral Fellowships
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2016
- 资助金额:
$ 72.7万 - 项目类别:
Postdoctoral Fellowships
Animal model of impaired autoregulation for study of age related vascular cognitive impairment
用于研究年龄相关血管认知障碍的自动调节受损动物模型
- 批准号:
9197938 - 财政年份:2016
- 资助金额:
$ 72.7万 - 项目类别:
The domestic cat as an animal model for age-related neurofibrillary tangles
家猫作为年龄相关神经原纤维缠结的动物模型
- 批准号:
24780283 - 财政年份:2012
- 资助金额:
$ 72.7万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Identification of candidate genes responsible for an increased susceptibility of age-related macular degeneration using an animal model and its application to gene diagnosis.
使用动物模型鉴定导致年龄相关性黄斑变性易感性增加的候选基因及其在基因诊断中的应用。
- 批准号:
22591939 - 财政年份:2010
- 资助金额:
$ 72.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MT1-MMP-based Animal Model of Age-related Macular Degeneration (AMD)
基于 MT1-MMP 的年龄相关性黄斑变性 (AMD) 动物模型
- 批准号:
8101435 - 财政年份:2008
- 资助金额:
$ 72.7万 - 项目类别:
MT1-MMP-based Animal Model of Age-related Macular Degeneration (AMD)
基于 MT1-MMP 的年龄相关性黄斑变性 (AMD) 动物模型
- 批准号:
7481783 - 财政年份:2008
- 资助金额:
$ 72.7万 - 项目类别:
A novel molecular paradigm of age-related macular degeneration in view of the social trend in nocturnal: An approach using an animal model
鉴于夜间活动的社会趋势,年龄相关性黄斑变性的新分子范式:使用动物模型的方法
- 批准号:
20791248 - 财政年份:2008
- 资助金额:
$ 72.7万 - 项目类别:
Grant-in-Aid for Young Scientists (B)